Exact Mass: 488.2536
Exact Mass Matches: 488.2536
Found 345 metabolites which its exact mass value is equals to given mass value 488.2536
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Jamaicamide B
7-Sulfocholic acid
7-Sulfocholic acid is a naturally occurring bile acid sulfate conjugate that has been identified in human bile (PMID: 7320139) and human urine. (PMID: 3584362). In mice significantly less cholic acid 7-sulfate (5-7\\%) is present in bladder bile and small intestine than in the cecum, colon, or feces (>80\\%). (PMID: 954753). 7-Sulfocholic acid is a naturally occurring bile acid sulfate conjugate that has been identified in human bile (PMID: 7320139) and human urine. (PMID: 3584362)
alpha-Ionol O-[arabinosyl-(1->6)-glucoside]
alpha-Ionol O-[arabinosyl-(1->6)-glucoside] is found in fruits. alpha-Ionol O-[arabinosyl-(1->6)-glucoside] is a constituent of Rubus idaeus (raspberry) fruit. Constituent of Rubus idaeus (raspberry) fruit. alpha-Ionol O-[arabinosyl-(1->6)-glucoside] is found in fruits and red raspberry.
12-O-(6-O-malonyl-beta-D-glucopyranosyl)-campherenane-2-endo,12-diol
Lys Val Asn Glu
Glu Val Ile Glu
Asp Ile Asn Lys
Asn Ile Asp Lys
Asn Ile Lys Asp
3a-Sulfate-7a,12a-(OH)2-5b-cholanic acid
BA-143-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
(4R)-4-((3R,5R,7R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
(R)-4-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Ala Gly Arg Trp
Ala Gly Trp Arg
Ala Arg Gly Trp
Ala Arg Trp Gly
Ala Trp Gly Arg
Ala Trp Arg Gly
Asp Glu Ile Ile
Asp Glu Ile Leu
Asp Glu Leu Ile
Asp Glu Leu Leu
Asp Ile Glu Ile
Asp Ile Glu Leu
Asp Ile Ile Glu
Asp Ile Lys Asn
Asp Ile Leu Glu
Asp Lys Ile Asn
Asp Lys Leu Asn
Asp Lys Asn Ile
Asp Lys Asn Leu
Asp Lys Gln Val
Asp Lys Val Gln
Asp Leu Glu Ile
Asp Leu Glu Leu
Asp Leu Ile Glu
Asp Leu Lys Asn
Asp Leu Leu Glu
Asp Leu Asn Lys
Asp Asn Ile Lys
Asp Asn Lys Ile
Asp Asn Lys Leu
Asp Asn Leu Lys
Asp Gln Lys Val
Asp Gln Val Lys
Asp Val Lys Gln
Asp Val Gln Lys
Glu Asp Ile Ile
Glu Asp Ile Leu
Glu Asp Leu Ile
Glu Asp Leu Leu
Glu Glu Ile Val
Glu Glu Leu Val
Glu Glu Val Ile
Glu Glu Val Leu
Glu Ile Asp Ile
Glu Ile Asp Leu
Glu Ile Glu Val
Glu Ile Ile Asp
Glu Ile Leu Asp
Glu Ile Val Glu
Glu Lys Asn Val
Glu Lys Val Asn
Glu Leu Asp Ile
Glu Leu Asp Leu
Glu Leu Glu Val
Glu Leu Ile Asp
Glu Leu Leu Asp
Glu Leu Val Glu
Glu Asn Lys Val
Glu Asn Val Lys
Glu Val Glu Ile
Glu Val Glu Leu
Glu Val Lys Asn
Glu Val Leu Glu
Glu Val Asn Lys
Gly Ala Arg Trp
Gly Ala Trp Arg
Gly Arg Ala Trp
Gly Arg Trp Ala
Gly Trp Ala Arg
Gly Trp Arg Ala
His His Pro Val
His His Val Pro
His Pro His Val
His Pro Val His
His Val His Pro
His Val Pro His
Ile Asp Glu Ile
Ile Asp Glu Leu
Ile Asp Ile Glu
Ile Asp Lys Asn
Ile Asp Leu Glu
Ile Asp Asn Lys
Ile Glu Asp Ile
Ile Glu Asp Leu
Ile Glu Glu Val
Ile Glu Ile Asp
Ile Glu Leu Asp
Ile Glu Val Glu
Ile Ile Asp Glu
Ile Ile Glu Asp
Ile Lys Asp Asn
Ile Lys Asn Asp
Ile Leu Asp Glu
Ile Leu Glu Asp
Ile Asn Asp Lys
Ile Asn Lys Asp
Ile Pro Pro Tyr
Ile Pro Tyr Pro
Ile Gln Gln Thr
Ile Gln Thr Gln
Ile Thr Gln Gln
Ile Val Glu Glu
Ile Tyr Pro Pro
Lys Asp Ile Asn
Lys Asp Leu Asn
Lys Asp Asn Ile
Lys Asp Asn Leu
Lys Asp Gln Val
Lys Asp Val Gln
Lys Glu Asn Val
Lys Glu Val Asn
Lys Ile Asp Asn
Lys Ile Asn Asp
Lys Leu Asp Asn
Lys Leu Asn Asp
Lys Asn Asp Ile
Lys Asn Asp Leu
Lys Asn Glu Val
Lys Asn Ile Asp
Lys Asn Leu Asp
Lys Asn Val Glu
Lys Gln Asp Val
Lys Gln Val Asp
Lys Val Asp Gln
Lys Val Glu Asn
Lys Val Gln Asp
Leu Asp Glu Ile
Leu Asp Glu Leu
Leu Asp Ile Glu
Leu Asp Lys Asn
Leu Asp Leu Glu
Leu Asp Asn Lys
Leu Glu Asp Ile
Leu Glu Asp Leu
Leu Glu Glu Val
Leu Glu Ile Asp
Leu Glu Leu Asp
Leu Glu Val Glu
Leu Ile Asp Glu
Leu Ile Glu Asp
Leu Lys Asp Asn
Leu Lys Asn Asp
Leu Leu Asp Glu
Leu Leu Glu Asp
Leu Asn Asp Lys
Leu Asn Lys Asp
Leu Pro Pro Tyr
Leu Pro Tyr Pro
Leu Gln Gln Thr
Leu Gln Thr Gln
Leu Thr Gln Gln
Leu Val Glu Glu
Leu Tyr Pro Pro
Asn Asp Ile Lys
Asn Asp Lys Ile
Asn Asp Lys Leu
Asn Asp Leu Lys
Asn Glu Lys Val
Asn Glu Val Lys
Asn Lys Asp Ile
Asn Lys Asp Leu
Asn Lys Glu Val
Asn Lys Ile Asp
Asn Lys Leu Asp
Asn Lys Val Glu
Asn Leu Asp Lys
Asn Leu Lys Asp
Asn Val Glu Lys
Asn Val Lys Glu
Pro His His Val
Pro His Val His
Pro Ile Pro Tyr
Pro Ile Tyr Pro
Pro Leu Pro Tyr
Pro Leu Tyr Pro
Pro Pro Ile Tyr
Pro Pro Leu Tyr
Pro Pro Tyr Ile
Pro Pro Tyr Leu
Pro Val His His
Pro Tyr Ile Pro
Pro Tyr Leu Pro
Pro Tyr Pro Ile
Pro Tyr Pro Leu
Gln Asp Lys Val
Gln Asp Val Lys
Gln Ile Gln Thr
Gln Ile Thr Gln
Gln Lys Asp Val
Gln Lys Val Asp
Gln Leu Gln Thr
Gln Leu Thr Gln
Gln Gln Ile Thr
Gln Gln Leu Thr
Gln Gln Thr Ile
Gln Gln Thr Leu
Gln Thr Ile Gln
Gln Thr Leu Gln
Gln Thr Gln Ile
Gln Thr Gln Leu
Gln Val Asp Lys
Gln Val Lys Asp
Arg Ala Gly Trp
Arg Ala Trp Gly
Arg Gly Ala Trp
Arg Gly Trp Ala
Arg Trp Ala Gly
Arg Trp Gly Ala
Thr Ile Gln Gln
Thr Leu Gln Gln
Thr Gln Ile Gln
Thr Gln Leu Gln
Thr Gln Gln Ile
Thr Gln Gln Leu
Val Asp Lys Gln
Val Asp Gln Lys
Val Glu Glu Ile
Val Glu Glu Leu
Val Glu Ile Glu
Val Glu Lys Asn
Val Glu Leu Glu
Val Glu Asn Lys
Val His His Pro
Val His Pro His
Val Ile Glu Glu
Val Lys Asp Gln
Val Lys Glu Asn
Val Lys Asn Glu
Val Lys Gln Asp
Val Leu Glu Glu
Val Asn Glu Lys
Val Asn Lys Glu
Val Pro His His
Val Gln Asp Lys
Val Gln Lys Asp
Trp Ala Gly Arg
Trp Ala Arg Gly
Trp Gly Ala Arg
Trp Gly Arg Ala
Trp Arg Ala Gly
Trp Arg Gly Ala
Tyr Ile Pro Pro
Tyr Leu Pro Pro
Tyr Pro Ile Pro
Tyr Pro Leu Pro
Tyr Pro Pro Ile
Tyr Pro Pro Leu
(3a,5b,7a,12a), 3,12-dihydroxy-7-(sulfooxy)-Cholan-24-oic acid
(3a,5b,7a,12a)-3,7-dihydroxy-12-(sulfooxy)cholan-24-oic acid
alpha-Ionol O-[arabinosyl-(1->6)-glucoside]
N-(3-(4-(4-Methoxyphenyl)piperazin-1-yl)propyl)-2-(1-methyl-6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl)acetamide
L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine
(2S)-5-[[(2S)-6-amino-1-[[(2R)-1-[[(1R)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoic acid
N-[(2S)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-N-{1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl}-L-threoninamide
N-[(2R)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-N-{1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl}-L-threoninamide
6-methoxy-3-[[2-oxolanylmethyl-[1-[1-(phenylmethyl)-5-tetrazolyl]propyl]amino]methyl]-1H-quinolin-2-one
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methoxyanilino)-N-(2-methylbutan-2-yl)-2-(1-methyl-2-pyrrolyl)acetamide
6-ethoxy-3-[[2-oxolanylmethyl-[[1-(2-phenylethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1,3-thiazol-2-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1,3-thiazol-2-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[3-(Succinimidyloxycarbonyl)propyl]-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydro-1-azonianaphthacene
(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-7-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
2,3-dihydroxypropyl [2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] hydrogen phosphate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(E,9E)-9-(chloromethylidene)-N-[(E)-3-methoxy-5-[(2S)-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-enyl]-6-methyltetradec-4-en-13-ynamide
kanamycin X(3+)
An organic cation obtained by protonation of the primary amino groups of kanamycin X.
kanamycin D(3+)
An organic cation obtained by protonation of the primary amino groups of kanamycin D.
TMC-89A
An epoxide that is oxiran-2-ylmethanol which is acylated at position 2 by an N-[(2R)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-L-threonylleucinyl group. It is a proteasome inhibitor isolated from Streptomyces sp. TC 1087.
TMC-89B
An epoxide that is oxiran-2-ylmethanol which is acylated at position 2 by an N-[(2S)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-L-threonylleucinyl group. It is a proteasome inhibitor isolated from Streptomyces sp. TC 1087.
3-deamino-3-hydroxykanamycin C(3+)
An organic cation obtained by protonation of the primary amino groups of 3-deamino-3-hydroxykanamycin C.